October 2020 Issue - Endovascular Today

Table of Contents

Issue

October 2020

Interventional Oncology

Expanding Applicability and Access

In This Issue

Guest Chief Medical Editors' Page

Exploring New Dimensions of Interventional Oncology

By Rahul A. Sheth, MD, and Alda L. Tam, MD, MBA, FSIR

Cover Stories

Year in Review: Top Papers in Interventional Oncology

An overview of the most significant interventional oncology articles published in the recent literature and summaries on their impact on the field.

By Eric Wehrenberg-Klee, MD, and Suvranu “Shoey” Ganguli, MD, FSIR

Vascular Oncologic Emergencies

A review of arterial and venous complications of malignancy and oncologic care that necessitate urgent transcatheter intervention.

By Lin L. Zhu, MD, PhD; Anne M. Covey, MD; and Amy R. Deipolyi, MD, PhD

Portomesenteric Intervention in the Cancer Patient

A review of patient selection and treatment approaches.

By Joshua D. Kuban, MD; Armeen Mahvash, MD; and Rahul A. Sheth, MD

Vertebral Augmentation and Ablation in Cancer Patients With Spine Metastases

Insights into the pivotal role these methods play in the multidisciplinary management of spinal metastases and the differences between treatment for pathologic compression and osteoporotic fractures.

By Rahul A. Sheth, MD, and Steven Yevich, MD, MPH

Next Horizons: Interventional Neuro-Oncology

A look at the expanding role of interventional oncology for central nervous system and head and neck cancers.

By Stephen Chen, MD, and Peter Kan, MD, MPH, FRCSC, FAANS

Disparities in Access to Care

Social determinants of health related to interventional radiology overall, access to liver-directed therapies and transplantation, and the role of artificial intelligence.

With Laura Findeiss, MD, FSIR, FAHA; Resmi Charalel, MD, MPH; Sarah B. White, MD, MS, FSIR; Veronica M. Loy, DO; and Julius Chapiro, MD, PhD

Featured Technology

Sponsored by Boston Scientific Corporation

Advanced Endovascular Interventions With Ultrasound-Accelerated Thrombolysis in Intermediate-Risk Pulmonary Embolism

An overview of management of intermediate-risk patients with ultrasound-accelerated thrombolysis and key considerations in treating those in the “gray zone.”

By Michael R. Jaff, DO

In This Issue

Most Read Articles